Investor Presentaiton

- Easyhaler One device with several therapy options for patients with asthma or Chronic Obstructive Pulmonary Disease (COPD) • Easyhaler Ⓡ portfolio consists of 6 dry-powder inhaler (DPI) products with several well-known generic active substances for the treatment of patients with asthma or COPD. 54 Standard footprint Carbon Neutral Product SALMETEROL/ FLUTICASONE PROPIONATE¹ BUDESONIDE / FORMOTEROL² SALBUTAMOL³ FORMOTEROL4 BUDESONIDE5 BECLOMETASONE6 • Key benefits: - - Wide range of different therapies administered from one type of DPI Easy and quick to teach, learn and use High accuracy and consistency of dosing even with low inhalation capacity Fully carbon neutral product range supporting sustainability goals of Orion Investor Presentation Orion Corporation ORION

View entire presentation